Holen Sie sich die Stockscreener-App
3.7101
1.85%
-0.0699
Schlusskurs vom Vortag:
$3.78
Offen:
$3.76
24-Stunden-Volumen:
9,108
Relative Volume:
0.25
Marktkapitalisierung:
$6.31M
Einnahmen:
$14.91M
Nettoeinkommen (Verlust:
$-3.56M
KGV:
-1.5086
EPS:
-2.4593
Netto-Cashflow:
$-1.37M
1W Leistung:
+1.93%
1M Leistung:
+2.49%
6M Leistung:
+15.94%
1J Leistung:
+39.48%
1-Tages-Spanne:
$3.71
$3.78
1-Wochen-Bereich:
$3.65
$3.892
52-Wochen-Spanne:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Firmenname
Sonoma Pharmaceuticals Inc
Sektor
Telefon
800-759-9305
Adresse
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Vergleichen Sie SNOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.7101 | 6.43M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
126.35 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.33 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.92 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.07 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
50.30 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten
What catalysts could drive Sonoma Pharmaceuticals Inc. stock higher2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
Is Sonoma Pharmaceuticals Inc. stock resilient to inflationJuly 2025 Market Mood & Community Trade Idea Sharing Platform - ulpravda.ru
Will Sonoma Pharmaceuticals Inc. stock beat EPS estimates2025 Sector Review & Verified Stock Trade Ideas - ulpravda.ru
What dividend safety score for Sonoma Pharmaceuticals Inc. stockJuly 2025 Market Mood & Real-Time Market Trend Scan - ulpravda.ru
Published on: 2026-01-08 01:30:55 - ulpravda.ru
Head to Head Comparison: Ocular Therapeutix (NASDAQ:OCUL) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Sonoma Pharmaceuticals issues annual equity grants to executives and directors - Investing.com Nigeria
Sonoma Pharmaceuticals issues annual equity grants to executives and directors By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals (SNOA) awards 5,000 RSUs to Controller Dal Poggetto - Stock Titan
EFC recently clinched a ₹183 cr interior turnkey fit‑out project with a major Indian MNCMarket Entry Points & Budget Friendly Growth - bollywoodhelpline.com
Shilchar Technologies Limited Trading Near Value Zone — Recovery AheadResistance Breakout Alerts & Explosive Capital Gains - bollywoodhelpline.com
Fundamentals Check: Will Sonoma Pharmaceuticals Inc. stock benefit from M&A activity2025 Bull vs Bear & Precise Buy Zone Identification - moha.gov.vn
Intraday Charts Show Spike in Vineet Laboratories Limited ActivityLow Beta Stocks & Low Cost Market Tips - Bollywood Helpline
Why Sonoma Pharmaceuticals Inc. stock could see breakout soonJuly 2025 Recap & Consistent Profit Trade Alerts - DonanımHaber
Is Sonoma Pharmaceuticals Inc. stock attractive for growth ETFs2025 Market WrapUp & Weekly High Return Forecasts - DonanımHaber
Published on: 2025-12-18 21:37:00 - Улправда
Dividend Income and re investment StrategyInterest Rate Changes & Discover Top Gainers in Every Sector - Bollywood Helpline
Demand for Scar Treatment in UK | Global Market Analysis Report2035 - Fact.MR
What analysts say about Sonoma Pharmaceuticals Inc stockMoving Average Strategies & Free Real-Time Trading Alerts Every Day - earlytimes.in
What analysts say about Sonoma Pharmaceuticals Inc O8Z stockConsumer Goods Stocks & Low Risk Trading Plans - earlytimes.in
Sonoma Pharmaceuticals (SNOA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appeals to dividend investorsWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
How Sonoma Pharmaceuticals Inc. (O8Z) stock compares with tech leadersJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
Sonoma Pharmaceuticals, Inc. (SNOA) 10.6% in After-hours: Strong Surge Amid Routine Trading - Stocks Telegraph
What drives Sonoma Pharmaceuticals Inc stock priceAnalyst Downgrades & Free High Return Strategy Alerts - earlytimes.in
Sonoma Pharmaceuticals Inc. (SNOA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Woodward reports record sales, earnings for 2025 - BizWest
Sonoma Pharmaceuticals, Inc.Common Stock (NQ: SNOA - Markets Financial Content
Sonoma Pharmaceuticals, Inc. (SNOA) stock price, news, quote and history - Yahoo Finance UK
Is Sonoma Pharmaceuticals Inc. (O8Z) stock prepared for digital transitionQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appears on watchlistsQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. (O8Z) stock attractive post correctionWall Street Watch & Daily Oversold Bounce Ideas - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock stacks up against competitorsInsider Buying & Real-Time Volume Analysis Alerts - newser.com
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
Published on: 2025-11-19 13:22:41 - newser.com
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyQuarterly Portfolio Review & Free High Return Stock Watch Alerts - newser.com
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - newser.com
Sonoma Pharmaceuticals Inc. stock volume spike explainedJuly 2025 Movers & Accurate Intraday Trading Signals - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 00:56:45 - newser.com
New CEOs for AdvanCell, Sonoma - BioCentury
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):